ETBX-061
UNII 17K7SN702N

Substance Identification & Data

This profile provides standardized clinical and technical data for Etbx-061, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 17K7SN702N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2171550-29-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
17K7SN702N
CAS Registry Number
2171550-29-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ETBX-061
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C143035
National Cancer Institute reference terminology for clinical and research data.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
NCBI Taxonomy
28285
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Etbx-061. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ADENOVIRAL BRACHYURY VACCINE ETBX-061
AN ADENOVIRUS VECTOR CANCER VACCINE COMPOSED OF A REPLICATION-DEFECTIVE, SER OTYPE 5 ADENOVIRUS (AD5) THAT HAS BEEN MODIFIED BY REMOVAL OF THE E1, E2B AND E3 GENES AND INSERTION OF A MODIFIED HUMAN MUCIN 1 GENE ENCODING AGONIST EPITOPES DESIGNED TO INCREASE CYTOTOXIC T LYMPHOCYTE ANTITUMOR IMMUNE RESPONSES
ETBX-061

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus